Bupropion Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 29 pharmaceutical companies such as SUN PHARM, AUROBINDO PHARMA USA, RISING and others. It is marketed under 4 brand names, including BUPROPION HYDROCHLORIDE, FORFIVO XL, CONTRAVE and others. Available in 8 different strengths, such as 200MG, 100MG, 150MG and others, and administered through 2 routes including TABLET, EXTENDED RELEASE;ORAL, TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 29 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"84788","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"78bfd13ae7384cd2a3fe","publication_number":"US7375111B2","cleaned_patent_number":"7375111","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-26","publication_date":"2008-05-20","legal_status":"Granted"}	US7375111B2 Formulation	20 May, 2008	Granted	26 Mar, 2025
{"application_id":"84855","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"f4ab2e8a55494ba288db","publication_number":"US9107837B2","cleaned_patent_number":"9107837","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-06-04","publication_date":"2015-08-18","legal_status":"Granted"}	US9107837B2	18 Aug, 2015	Granted	04 Jun, 2027
{"application_id":"84818","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"c1bb9e6e538e43f387d8","publication_number":"US9125868B2","cleaned_patent_number":"9125868","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-08","publication_date":"2015-09-08","legal_status":"Granted"}	US9125868B2	08 Sep, 2015	Granted	08 Nov, 2027
{"application_id":"84823","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"c1bb9e6e538e43f387d8","publication_number":"US20200352863A1","cleaned_patent_number":"12048769","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-08","publication_date":"2020-11-12","legal_status":"Abandoned"}	US12048769B2	12 Nov, 2020	Abandoned	08 Nov, 2027
{"application_id":"84819","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"c1bb9e6e538e43f387d8","publication_number":"US10307376B2","cleaned_patent_number":"10307376","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-08","publication_date":"2019-06-04","legal_status":"Granted"}	US10307376B2	04 Jun, 2019	Granted	08 Nov, 2027
{"application_id":"84995","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"47cd997faa684290a198","publication_number":"US8318788B2","cleaned_patent_number":"8318788","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-08","publication_date":"2012-11-27","legal_status":"Patented case"}	US8318788B2	27 Nov, 2012	Patented case	08 Nov, 2027
{"application_id":"84799","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"c1bb9e6e538e43f387d8","publication_number":"US8722085B2","cleaned_patent_number":"8722085","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-08","publication_date":"2014-05-13","legal_status":"Granted"}	US8722085B2	13 May, 2014	Granted	08 Nov, 2027
{"application_id":"85077","ingredient":"BUPROPION HYDROCHLORIDE","trade_name":"FORFIVO XL","family_id":"fa8ff29d5e0a4293b65b","publication_number":"US7674479B2","cleaned_patent_number":"7674479","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-08-23","publication_date":"2010-03-09","legal_status":"Granted"}	US7674479B2 Formulation	09 Mar, 2010	Granted	23 Aug, 2028
{"application_id":"85024","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"47cd997faa684290a198","publication_number":"US8088786B2","cleaned_patent_number":"8088786","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-03","publication_date":"2012-01-03","legal_status":"Granted"}	US8088786B2 Formulation	03 Jan, 2012	Granted	03 Feb, 2029
{"application_id":"85030","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"2698804f96da4bd2a03f","publication_number":"US11324741B2","cleaned_patent_number":"11324741","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-29","publication_date":"2022-05-10","legal_status":"Granted"}	US11324741B2	10 May, 2022	Granted	29 May, 2029
{"application_id":"84864","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"f4ab2e8a55494ba288db","publication_number":"US8916195B2","cleaned_patent_number":"8916195","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-02-02","publication_date":"2014-12-23","legal_status":"Granted"}	US8916195B2	23 Dec, 2014	Granted	02 Feb, 2030
{"application_id":"84972","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"a25d0f137f20461c9b7b","publication_number":"US11033543B2","cleaned_patent_number":"11033543","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-01-10","publication_date":"2021-06-15","legal_status":"Granted"}	US11033543B2	15 Jun, 2021	Granted	10 Jan, 2031
{"application_id":"84990","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"a25d0f137f20461c9b7b","publication_number":"US9248123B2","cleaned_patent_number":"9248123","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-01-13","publication_date":"2016-02-02","legal_status":"Granted"}	US9248123B2	02 Feb, 2016	Granted	13 Jan, 2032
{"application_id":"84923","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"36e599b828c34fd49bd8","publication_number":"US11139056B2","cleaned_patent_number":"11139056","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-06-05","publication_date":"2021-10-05","legal_status":"Granted"}	US11139056B2	05 Oct, 2021	Granted	05 Jun, 2033
{"application_id":"84967","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"36e599b828c34fd49bd8","publication_number":"US10403170B2","cleaned_patent_number":"10403170","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-06-05","publication_date":"2019-09-03","legal_status":"Granted"}	US10403170B2	03 Sep, 2019	Granted	05 Jun, 2033
{"application_id":"84966","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"36e599b828c34fd49bd8","publication_number":"US9633575B2","cleaned_patent_number":"9633575","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-06-25","publication_date":"2017-04-25","legal_status":"Granted"}	US9633575B2	25 Apr, 2017	Granted	25 Jun, 2033
{"application_id":"108159","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"0c53bafe4a0543d2a582","publication_number":"US8569328B1","cleaned_patent_number":"8569328","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-29","publication_date":"2013-10-29","legal_status":"Granted"}	US8569328B2 Formulation	29 Oct, 2013	Granted	29 Oct, 2033
{"application_id":"84913","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"fedd7e26e7a3466ea267","publication_number":"US10828294B2","cleaned_patent_number":"10828294","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-02","publication_date":"2020-11-10","legal_status":"Expired"}	US10828294B2	10 Nov, 2020	Expired	02 Jul, 2034
{"application_id":"84872","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"fedd7e26e7a3466ea267","publication_number":"US10231964B2","cleaned_patent_number":"10231964","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-02","publication_date":"2019-03-19","legal_status":"Expired"}	US10231964B2	19 Mar, 2019	Expired	02 Jul, 2034
{"application_id":"84915","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"fedd7e26e7a3466ea267","publication_number":"US11998542B2","cleaned_patent_number":"11998542","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-02","publication_date":"2024-06-04","legal_status":"Granted"}	US11998542B2	04 Jun, 2024	Granted	02 Jul, 2034
{"application_id":"84914","ingredient":"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","trade_name":"CONTRAVE","family_id":"fedd7e26e7a3466ea267","publication_number":"US10835527B2","cleaned_patent_number":"10835527","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-02","publication_date":"2020-11-17","legal_status":"Expired"}	US10835527B2	17 Nov, 2020	Expired	02 Jul, 2034
{"application_id":"34498","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10881624B2","cleaned_patent_number":"10881624","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-01-05","legal_status":"Granted"}	US10881624B2	05 Jan, 2021	Granted	05 Nov, 2034
{"application_id":"34493","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10881657B2","cleaned_patent_number":"10881657","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-01-05","legal_status":"Granted"}	US10881657B2	05 Jan, 2021	Granted	05 Nov, 2034
{"application_id":"34499","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10894046B2","cleaned_patent_number":"10894046","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-01-19","legal_status":"Granted"}	US10894046B2	19 Jan, 2021	Granted	05 Nov, 2034
{"application_id":"34500","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10894047B2","cleaned_patent_number":"10894047","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-01-19","legal_status":"Patented case"}	US10894047B2	19 Jan, 2021	Patented case	05 Nov, 2034
{"application_id":"34501","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10898453B2","cleaned_patent_number":"10898453","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-01-26","legal_status":"Granted"}	US10898453B2	26 Jan, 2021	Granted	05 Nov, 2034
{"application_id":"1876","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10933034B2","cleaned_patent_number":"10933034","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-03-02","legal_status":"Granted"}	US10933034B2	02 Mar, 2021	Granted	05 Nov, 2034
{"application_id":"34505","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10945973B2","cleaned_patent_number":"10945973","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-03-16","legal_status":"Patented case"}	US10945973B2	16 Mar, 2021	Patented case	05 Nov, 2034
{"application_id":"34506","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10966941B2","cleaned_patent_number":"10966941","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-04-06","legal_status":"Granted"}	US10966941B2	06 Apr, 2021	Granted	05 Nov, 2034
{"application_id":"34508","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10966974B2","cleaned_patent_number":"10966974","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-04-06","legal_status":"Granted"}	US10966974B2	06 Apr, 2021	Granted	05 Nov, 2034
{"application_id":"34512","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11020389B2","cleaned_patent_number":"11020389","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-06-01","legal_status":"Granted"}	US11020389B2	01 Jun, 2021	Granted	05 Nov, 2034
{"application_id":"34514","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11058648B2","cleaned_patent_number":"11058648","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-07-13","legal_status":"Patented case"}	US11058648B2	13 Jul, 2021	Patented case	05 Nov, 2034
{"application_id":"34509","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11090300B2","cleaned_patent_number":"11090300","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-08-17","legal_status":"Granted"}	US11090300B2	17 Aug, 2021	Granted	05 Nov, 2034
{"application_id":"34517","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11096937B2","cleaned_patent_number":"11096937","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-08-24","legal_status":"Granted"}	US11096937B2	24 Aug, 2021	Granted	05 Nov, 2034
{"application_id":"34518","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11123343B2","cleaned_patent_number":"11123343","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-09-21","legal_status":"Granted"}	US11123343B2	21 Sep, 2021	Granted	05 Nov, 2034
{"application_id":"34521","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11129826B2","cleaned_patent_number":"11129826","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-09-28","legal_status":"Granted"}	US11129826B2	28 Sep, 2021	Granted	05 Nov, 2034
{"application_id":"34522","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11141388B2","cleaned_patent_number":"11141388","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-10-12","legal_status":"Granted"}	US11141388B2	12 Oct, 2021	Granted	05 Nov, 2034
{"application_id":"34524","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11141416B2","cleaned_patent_number":"11141416","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-10-12","legal_status":"Granted"}	US11141416B2	12 Oct, 2021	Granted	05 Nov, 2034
{"application_id":"34525","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11147808B2","cleaned_patent_number":"11147808","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-10-19","legal_status":"Granted"}	US11147808B2	19 Oct, 2021	Granted	05 Nov, 2034
{"application_id":"34526","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11185515B2","cleaned_patent_number":"11185515","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-11-30","legal_status":"Granted"}	US11185515B2	30 Nov, 2021	Granted	05 Nov, 2034
{"application_id":"34527","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11191739B2","cleaned_patent_number":"11191739","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-12-07","legal_status":"Granted"}	US11191739B2 Formulation	07 Dec, 2021	Granted	05 Nov, 2034
{"application_id":"34531","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11197839B2","cleaned_patent_number":"11197839","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-12-14","legal_status":"Patented case"}	US11197839B2 Formulation	14 Dec, 2021	Patented case	05 Nov, 2034
{"application_id":"34533","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11207281B2","cleaned_patent_number":"11207281","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2021-12-28","legal_status":"Granted"}	US11207281B2	28 Dec, 2021	Granted	05 Nov, 2034
{"application_id":"34534","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11213521B2","cleaned_patent_number":"11213521","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-01-04","legal_status":"Granted"}	US11213521B2	04 Jan, 2022	Granted	05 Nov, 2034
{"application_id":"34535","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11229640B2","cleaned_patent_number":"11229640","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-01-25","legal_status":"Granted"}	US11229640B2	25 Jan, 2022	Granted	05 Nov, 2034
{"application_id":"34537","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11234946B2","cleaned_patent_number":"11234946","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-02-01","legal_status":"Patented case"}	US11234946B2	01 Feb, 2022	Patented case	05 Nov, 2034
{"application_id":"34539","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11253491B2","cleaned_patent_number":"11253491","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-02-22","legal_status":"Granted"}	US11253491B2	22 Feb, 2022	Granted	05 Nov, 2034
{"application_id":"34540","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11253492B2","cleaned_patent_number":"11253492","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-02-22","legal_status":"Granted"}	US11253492B2	22 Feb, 2022	Granted	05 Nov, 2034
{"application_id":"34541","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11273133B2","cleaned_patent_number":"11273133","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-03-15","legal_status":"Granted"}	US11273133B2	15 Mar, 2022	Granted	05 Nov, 2034
{"application_id":"34528","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11273134B2","cleaned_patent_number":"11273134","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-03-15","legal_status":"Patented case"}	US11273134B2	15 Mar, 2022	Patented case	05 Nov, 2034
{"application_id":"34542","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11285118B2","cleaned_patent_number":"11285118","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-03-29","legal_status":"Granted"}	US11285118B2	29 Mar, 2022	Granted	05 Nov, 2034
{"application_id":"34543","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11285146B2","cleaned_patent_number":"11285146","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-03-29","legal_status":"Granted"}	US11285146B2	29 Mar, 2022	Granted	05 Nov, 2034
{"application_id":"34544","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11291638B2","cleaned_patent_number":"11291638","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-04-05","legal_status":"Granted"}	US11291638B2	05 Apr, 2022	Granted	05 Nov, 2034
{"application_id":"34545","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11291665B2","cleaned_patent_number":"11291665","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-04-05","legal_status":"Granted"}	US11291665B2	05 Apr, 2022	Granted	05 Nov, 2034
{"application_id":"34546","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11298351B2","cleaned_patent_number":"11298351","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-04-12","legal_status":"Granted"}	US11298351B2	12 Apr, 2022	Granted	05 Nov, 2034
{"application_id":"34548","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11298352B2","cleaned_patent_number":"11298352","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-04-12","legal_status":"Patented case"}	US11298352B2	12 Apr, 2022	Patented case	05 Nov, 2034
{"application_id":"34549","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11311534B2","cleaned_patent_number":"11311534","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-04-26","legal_status":"Granted"}	US11311534B2	26 Apr, 2022	Granted	05 Nov, 2034
{"application_id":"30488","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11344544B2","cleaned_patent_number":"11344544","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-05-31","legal_status":"Granted"}	US11344544B2	31 May, 2022	Granted	05 Nov, 2034
{"application_id":"34439","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11357744B2","cleaned_patent_number":"11357744","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-06-14","legal_status":"Granted"}	US11357744B2	14 Jun, 2022	Granted	05 Nov, 2034
{"application_id":"34440","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11364233B2","cleaned_patent_number":"11364233","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-06-21","legal_status":"Granted"}	US11364233B2	21 Jun, 2022	Granted	05 Nov, 2034
{"application_id":"34569","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11382874B2","cleaned_patent_number":"11382874","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-07-12","legal_status":"Granted"}	US11382874B2	12 Jul, 2022	Granted	05 Nov, 2034
{"application_id":"34570","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11419867B2","cleaned_patent_number":"11419867","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-08-23","legal_status":"Granted"}	US11419867B2	23 Aug, 2022	Granted	05 Nov, 2034
{"application_id":"34561","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11426370B2","cleaned_patent_number":"11426370","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-08-30","legal_status":"Granted"}	US11426370B2	30 Aug, 2022	Granted	05 Nov, 2034
{"application_id":"34563","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11426401B2","cleaned_patent_number":"11426401","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-08-30","legal_status":"Granted"}	US11426401B2	30 Aug, 2022	Granted	05 Nov, 2034
{"application_id":"34441","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11433067B2","cleaned_patent_number":"11433067","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-09-06","legal_status":"Granted"}	US11433067B2 Formulation	06 Sep, 2022	Granted	05 Nov, 2034
{"application_id":"106180","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11439636B1","cleaned_patent_number":"11439636","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-09-13","legal_status":"Granted"}	US11439636B2	13 Sep, 2022	Granted	05 Nov, 2034
{"application_id":"38804","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11478468B2","cleaned_patent_number":"11478468","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-10-25","legal_status":"Granted"}	US11478468B2	25 Oct, 2022	Granted	05 Nov, 2034
{"application_id":"42497","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11497721B2","cleaned_patent_number":"11497721","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-11-15","legal_status":"Granted"}	US11497721B2	15 Nov, 2022	Granted	05 Nov, 2034
{"application_id":"42555","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11510918B2","cleaned_patent_number":"11510918","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-11-29","legal_status":"Patented case"}	US11510918B2	29 Nov, 2022	Patented case	05 Nov, 2034
{"application_id":"42553","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11517542B2","cleaned_patent_number":"11517542","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-12-06","legal_status":"Granted"}	US11517542B2	06 Dec, 2022	Granted	05 Nov, 2034
{"application_id":"30325","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11517543B2","cleaned_patent_number":"11517543","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-12-06","legal_status":"Granted"}	US11517543B2	06 Dec, 2022	Granted	05 Nov, 2034
{"application_id":"42556","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11524007B2","cleaned_patent_number":"11524007","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-12-13","legal_status":"Granted"}	US11524007B2	13 Dec, 2022	Granted	05 Nov, 2034
{"application_id":"104808","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11524008B2","cleaned_patent_number":"11524008","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-12-13","legal_status":"Granted"}	US11524008B2	13 Dec, 2022	Granted	05 Nov, 2034
{"application_id":"30326","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11534414B2","cleaned_patent_number":"11534414","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2022-12-27","legal_status":"Granted"}	US11534414B2 Formulation	27 Dec, 2022	Granted	05 Nov, 2034
{"application_id":"34554","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11541021B2","cleaned_patent_number":"11541021","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2023-01-03","legal_status":"Granted"}	US11541021B2	03 Jan, 2023	Granted	05 Nov, 2034
{"application_id":"42499","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11541048B2","cleaned_patent_number":"11541048","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2023-01-03","legal_status":"Granted"}	US11541048B2	03 Jan, 2023	Granted	05 Nov, 2034
{"application_id":"105169","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11596627B2","cleaned_patent_number":"11596627","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2023-03-07","legal_status":"Patented case"}	US11596627B2	07 Mar, 2023	Patented case	05 Nov, 2034
{"application_id":"38640","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11617728B2","cleaned_patent_number":"11617728","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2023-04-04","legal_status":"Granted"}	US11617728B2	04 Apr, 2023	Granted	05 Nov, 2034
{"application_id":"1934","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11617747B2","cleaned_patent_number":"11617747","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2023-04-04","legal_status":"Patented case"}	US11617747B2	04 Apr, 2023	Patented case	05 Nov, 2034
{"application_id":"111540","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11779579B2","cleaned_patent_number":"11779579","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2023-10-10","legal_status":"Patented case"}	US11779579B2	10 Oct, 2023	Patented case	05 Nov, 2034
{"application_id":"107692","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US11969421B2","cleaned_patent_number":"11969421","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2024-04-30","legal_status":"Granted"}	US11969421B2	30 Apr, 2024	Granted	05 Nov, 2034
{"application_id":"34471","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9968568B2","cleaned_patent_number":"9968568","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-05-15","legal_status":"Granted"}	US9968568B2	15 May, 2018	Granted	05 Nov, 2034
{"application_id":"34473","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10064857B2","cleaned_patent_number":"10064857","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-09-04","legal_status":"Patented case"}	US10064857B2	04 Sep, 2018	Patented case	05 Nov, 2034
{"application_id":"34474","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10080727B2","cleaned_patent_number":"10080727","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-09-25","legal_status":"Granted"}	US10080727B2	25 Sep, 2018	Granted	05 Nov, 2034
{"application_id":"34475","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10092560B2","cleaned_patent_number":"10092560","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-10-09","legal_status":"Granted"}	US10092560B2	09 Oct, 2018	Granted	05 Nov, 2034
{"application_id":"1904","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10092561B2","cleaned_patent_number":"10092561","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-10-09","legal_status":"Granted"}	US10092561B2	09 Oct, 2018	Granted	05 Nov, 2034
{"application_id":"1901","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10105327B2","cleaned_patent_number":"10105327","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-10-23","legal_status":"Granted"}	US10105327B2	23 Oct, 2018	Granted	05 Nov, 2034
{"application_id":"34478","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10105361B2","cleaned_patent_number":"10105361","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-10-23","legal_status":"Granted"}	US10105361B2	23 Oct, 2018	Granted	05 Nov, 2034
{"application_id":"34479","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10251879B2","cleaned_patent_number":"10251879","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2019-04-09","legal_status":"Granted"}	US10251879B2	09 Apr, 2019	Granted	05 Nov, 2034
{"application_id":"34480","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10463634B2","cleaned_patent_number":"10463634","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2019-11-05","legal_status":"Patented case"}	US10463634B2	05 Nov, 2019	Patented case	05 Nov, 2034
{"application_id":"34481","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10512643B2","cleaned_patent_number":"10512643","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2019-12-24","legal_status":"Patented case"}	US10512643B2	24 Dec, 2019	Patented case	05 Nov, 2034
{"application_id":"34482","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10548857B2","cleaned_patent_number":"10548857","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-02-04","legal_status":"Granted"}	US10548857B2	04 Feb, 2020	Granted	05 Nov, 2034
{"application_id":"34483","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10596167B2","cleaned_patent_number":"10596167","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-03-24","legal_status":"Patented case"}	US10596167B2	24 Mar, 2020	Patented case	05 Nov, 2034
{"application_id":"34485","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10772850B2","cleaned_patent_number":"10772850","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-09-15","legal_status":"Granted"}	US10772850B2	15 Sep, 2020	Granted	05 Nov, 2034
{"application_id":"34489","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10786469B2","cleaned_patent_number":"10786469","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-09-29","legal_status":"Patented case"}	US10786469B2	29 Sep, 2020	Patented case	05 Nov, 2034
{"application_id":"34490","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10786496B2","cleaned_patent_number":"10786496","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-09-29","legal_status":"Granted"}	US10786496B2	29 Sep, 2020	Granted	05 Nov, 2034
{"application_id":"34491","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10799497B2","cleaned_patent_number":"10799497","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-10-13","legal_status":"Granted"}	US10799497B2	13 Oct, 2020	Granted	05 Nov, 2034
{"application_id":"34486","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10806710B2","cleaned_patent_number":"10806710","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-10-20","legal_status":"Granted"}	US10806710B2	20 Oct, 2020	Granted	05 Nov, 2034
{"application_id":"34494","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10864209B2","cleaned_patent_number":"10864209","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-12-15","legal_status":"Granted"}	US10864209B2	15 Dec, 2020	Granted	05 Nov, 2034
{"application_id":"1883","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10874663B2","cleaned_patent_number":"10874663","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-12-29","legal_status":"Granted"}	US10874663B2	29 Dec, 2020	Granted	05 Nov, 2034
{"application_id":"34496","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10874664B2","cleaned_patent_number":"10874664","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-12-29","legal_status":"Granted"}	US10874664B2	29 Dec, 2020	Granted	05 Nov, 2034
{"application_id":"1885","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10874665B2","cleaned_patent_number":"10874665","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2020-12-29","legal_status":"Granted"}	US10874665B2	29 Dec, 2020	Granted	05 Nov, 2034
{"application_id":"34447","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9205083B2","cleaned_patent_number":"9205083","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2015-12-08","legal_status":"Granted"}	US9205083B2	08 Dec, 2015	Granted	05 Nov, 2034
{"application_id":"34446","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9238032B2","cleaned_patent_number":"9238032","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-01-19","legal_status":"Granted"}	US9238032B2	19 Jan, 2016	Granted	05 Nov, 2034
{"application_id":"34464","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9278095B2","cleaned_patent_number":"9278095","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-03-08","legal_status":"Patented case"}	US9278095B2	08 Mar, 2016	Patented case	05 Nov, 2034
{"application_id":"34465","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9314462B2","cleaned_patent_number":"9314462","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-04-19","legal_status":"Granted"}	US9314462B2	19 Apr, 2016	Granted	05 Nov, 2034
{"application_id":"34466","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9370513B2","cleaned_patent_number":"9370513","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-06-21","legal_status":"Granted"}	US9370513B2	21 Jun, 2016	Granted	05 Nov, 2034
{"application_id":"34467","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9375429B2","cleaned_patent_number":"9375429","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-06-28","legal_status":"Granted"}	US9375429B2	28 Jun, 2016	Granted	05 Nov, 2034
{"application_id":"34468","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9408815B2","cleaned_patent_number":"9408815","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-08-09","legal_status":"Granted"}	US9408815B2	09 Aug, 2016	Granted	05 Nov, 2034
{"application_id":"34456","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9421176B1","cleaned_patent_number":"9421176","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-08-23","legal_status":"Granted"}	US9421176B2	23 Aug, 2016	Granted	05 Nov, 2034
{"application_id":"34458","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9457023B1","cleaned_patent_number":"9457023","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-10-04","legal_status":"Granted"}	US9457023B2	04 Oct, 2016	Granted	05 Nov, 2034
{"application_id":"34469","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9457025B2","cleaned_patent_number":"9457025","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-10-04","legal_status":"Granted"}	US9457025B2	04 Oct, 2016	Granted	05 Nov, 2034
{"application_id":"1916","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9474731B1","cleaned_patent_number":"9474731","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-10-25","legal_status":"Granted"}	US9474731B2	25 Oct, 2016	Granted	05 Nov, 2034
{"application_id":"34448","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9486450B2","cleaned_patent_number":"9486450","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2016-11-08","legal_status":"Granted"}	US9486450B2	08 Nov, 2016	Granted	05 Nov, 2034
{"application_id":"1913","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9700528B2","cleaned_patent_number":"9700528","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2017-07-11","legal_status":"Granted"}	US9700528B2	11 Jul, 2017	Granted	05 Nov, 2034
{"application_id":"34460","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9700553B2","cleaned_patent_number":"9700553","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2017-07-11","legal_status":"Granted"}	US9700553B2	11 Jul, 2017	Granted	05 Nov, 2034
{"application_id":"34457","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9707191B2","cleaned_patent_number":"9707191","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2017-07-18","legal_status":"Granted"}	US9707191B2	18 Jul, 2017	Granted	05 Nov, 2034
{"application_id":"34463","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9763932B2","cleaned_patent_number":"9763932","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2017-09-19","legal_status":"Granted"}	US9763932B2	19 Sep, 2017	Granted	05 Nov, 2034
{"application_id":"34459","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9861595B2","cleaned_patent_number":"9861595","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-01-09","legal_status":"Granted"}	US9861595B2	09 Jan, 2018	Granted	05 Nov, 2034
{"application_id":"34470","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9867819B2","cleaned_patent_number":"9867819","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-01-16","legal_status":"Granted"}	US9867819B2	16 Jan, 2018	Granted	05 Nov, 2034
{"application_id":"34472","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10058518B2","cleaned_patent_number":"10058518","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2018-08-28","legal_status":"Granted"}	US10058518B2	28 Aug, 2018	Granted	05 Nov, 2034
{"application_id":"109613","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US20230045675A1","cleaned_patent_number":"12109178","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2024-10-08","legal_status":"Pending"}	US12109178B2	08 Oct, 2024	Pending	05 Nov, 2034
{"application_id":"34449","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9168234B2","cleaned_patent_number":"9168234","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2015-10-27","legal_status":"Granted"}	US9168234B2	27 Oct, 2015	Granted	05 Nov, 2034
{"application_id":"34444","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US9198905B2","cleaned_patent_number":"9198905","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-05","publication_date":"2015-12-01","legal_status":"Granted"}	US9198905B2	01 Dec, 2015	Granted	05 Nov, 2034
{"application_id":"34488","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10780066B2","cleaned_patent_number":"10780066","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-09","publication_date":"2020-09-22","legal_status":"Granted"}	US10780066B2	22 Sep, 2020	Granted	09 Nov, 2034
{"application_id":"34507","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10966942B2","cleaned_patent_number":"10966942","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-01-07","publication_date":"2021-04-06","legal_status":"Granted"}	US10966942B2	06 Apr, 2021	Granted	07 Jan, 2040
{"application_id":"34502","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10925842B2","cleaned_patent_number":"10925842","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-01-07","publication_date":"2021-02-23","legal_status":"Granted"}	US10925842B2	23 Feb, 2021	Granted	07 Jan, 2040
{"application_id":"1892","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10780064B2","cleaned_patent_number":"10780064","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-01-07","publication_date":"2020-09-22","legal_status":"Granted"}	US10780064B2	22 Sep, 2020	Granted	07 Jan, 2040
{"application_id":"1875","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"1385472fdc1e410d9aa9","publication_number":"US10940124B2","cleaned_patent_number":"10940124","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-01-07","publication_date":"2021-03-09","legal_status":"Granted"}	US10940124B2	09 Mar, 2021	Granted	07 Jan, 2040
{"application_id":"114725","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"b32397240d614969bcfe","publication_number":"US11896563B2","cleaned_patent_number":"11896563","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-12-01","publication_date":"2024-02-13","legal_status":"Granted"}	US11896563B2	13 Feb, 2024	Granted	01 Dec, 2041
{"application_id":"242150","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"","publication_number":"US12310961B2","cleaned_patent_number":"12310961","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-01-20","publication_date":"2025-05-27","legal_status":"Granted"}	US12310961B2	27 May, 2025	Granted	20 Jan, 2043
{"application_id":"116362","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"","publication_number":"US11717518B1","cleaned_patent_number":"11717518","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-01-20","publication_date":"2023-08-08","legal_status":"Granted"}	US11717518B2	08 Aug, 2023	Granted	20 Jan, 2043
{"application_id":"122914","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"","publication_number":"US11925636B2","cleaned_patent_number":"11925636","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-01-20","publication_date":"2024-03-12","legal_status":"Granted"}	US11925636B2	12 Mar, 2024	Granted	20 Jan, 2043
{"application_id":"139408","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"","publication_number":"US12156914B2","cleaned_patent_number":"12156914","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-01-20","publication_date":"2024-12-03","legal_status":"Granted"}	US12156914B2 Formulation	03 Dec, 2024	Granted	20 Jan, 2043
{"application_id":"122915","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US11883373B2","cleaned_patent_number":"11883373","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-01-23","publication_date":"2024-01-30","legal_status":"Patented case"}	US11883373B2	30 Jan, 2024	Patented case	23 Jan, 2043
{"application_id":"116361","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US11730706B1","cleaned_patent_number":"11730706","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-01-23","publication_date":"2023-08-22","legal_status":"Granted"}	US11730706B2	22 Aug, 2023	Granted	23 Jan, 2043
{"application_id":"123462","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"","publication_number":"US11986444B2","cleaned_patent_number":"11986444","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-02-15","publication_date":"2024-05-21","legal_status":"Granted"}	US11986444B2	21 May, 2024	Granted	15 Feb, 2043
{"application_id":"124174","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"","publication_number":"US12036191B1","cleaned_patent_number":"12036191","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-02-15","publication_date":"2024-07-16","legal_status":"Granted"}	US12036191B2	16 Jul, 2024	Granted	15 Feb, 2043
{"application_id":"116363","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US11752144B1","cleaned_patent_number":"11752144","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-02-23","publication_date":"2023-09-12","legal_status":"Granted"}	US11752144B2	12 Sep, 2023	Granted	23 Feb, 2043
{"application_id":"138513","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US12146889B2","cleaned_patent_number":"12146889","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-02-23","publication_date":"2024-11-19","legal_status":"Patented case"}	US12146889B2	19 Nov, 2024	Patented case	23 Feb, 2043
{"application_id":"124173","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US12042473B2","cleaned_patent_number":"12042473","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-02-23","publication_date":"2024-07-23","legal_status":"Granted"}	US12042473B2	23 Jul, 2024	Granted	23 Feb, 2043
{"application_id":"121176","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US11839612B1","cleaned_patent_number":"11839612","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-03-02","publication_date":"2023-12-12","legal_status":"Granted"}	US11839612B2	12 Dec, 2023	Granted	02 Mar, 2043
{"application_id":"121175","ingredient":"BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE","trade_name":"AUVELITY","family_id":"53bcd64767304989a0e4","publication_number":"US11844797B1","cleaned_patent_number":"11844797","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2043-04-20","publication_date":"2023-12-19","legal_status":"Granted"}	US11844797B2	19 Dec, 2023	Granted	20 Apr, 2043

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Bupropion Hydrochloride

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.